These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34867785)

  • 1. Effects of Proton Pump Inhibitor Therapy,
    Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
    Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
    Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
    Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
    Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
    J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors.
    Larkin CJ; Watson RGP ; Sloan JM; Stevenson M; Ardill JE; Buchanan D
    Scand J Gastroenterol; 2000 Jun; 35(6):578-82. PubMed ID: 10912656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
    Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
    PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
    Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
    Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antral Helicobacter pylori infection, hypergastrinemia and peptic ulcers: effect of eradicating the organism.
    Park SM; Yoo BC; Lee HR; Yoon JH; Cha YJ
    Korean J Intern Med; 1993 Jan; 8(1):19-24. PubMed ID: 8268142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
    Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
    J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
    Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
    Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
    el-Nujumi A; Williams C; Ardill JE; Oien K; McColl KE
    Gut; 1998 Feb; 42(2):159-65. PubMed ID: 9536937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
    Wagner S; Haruma K; Gladziwa U; Soudah B; Gebel M; Bleck J; Schmidt H; Manns M
    Am J Gastroenterol; 1994 Aug; 89(8):1211-8. PubMed ID: 8053437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin and Helicobacter pylori in low-grade MALT lymphoma patients.
    Ohashi S; Segawa K; Okamura S; Urano F; Kanamori S; Hosoi T; Ishikawa H; Kanamori A; Kitabatake S; Sano H; Kobayashi T; Maeda M
    Scand J Gastroenterol; 2002 Mar; 37(3):279-86. PubMed ID: 11916189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
    Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
    Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
    Katelaris PH; Seow F; Lin BP; Napoli J; Ngu MC; Jones DB
    Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.